BARBARA DAVIDSON: Open Payments
NPI 1124563226 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 17 payments from 11 companies in 2025. Trend: 2023 $92 · 2024 $346 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 1 | $110 |
| Astellas Pharma US Inc | 1 | $98 |
| Janssen Biotech, Inc. | 2 | $98 |
| ABBVIE INC. | 3 | $82 |
| COLOPLAST CORP | 3 | $80 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| ABC Home Medical Supply, Inc. | 1 | $26 |
| IMMUNITYBIO, INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: XTANDI, JATENZO, Luja Coude, RYBREVANT, LUPRON DEPOT, GEMTESA, BOTOX, ERLEADA.
Industry payments across CA — which companies pay providers there.
